Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
| Actual shortage: | 30 (23%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 29 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
7 (23%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-TOPIRAMATE | 100MG | TABLET | Actual shortage | 2024-01-29 | 2024-01-29 | 217684 |
| MINT-TOPIRAMATE | 200MG | TABLET | Actual shortage | 2024-01-29 | 2024-01-29 | 217687 |
| MINT-PRAVASTATIN | 20MG | TABLET TABLET | Actual shortage | 2024-01-26 | 2024-03-25 | 217378 |
| MINT-METFORMIN | 500MG | TABLET | Actual shortage | 2019-02-04 | 2019-02-05 | 74455 |
| MINT-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Actual shortage | 2021-10-21 | 2023-01-03 | 147784 |
| MINT-LOSARTAN/HCTZ DS | 25.0MG 100.0MG | TABLET | Actual shortage | 2021-10-21 | 2023-01-03 | 147790 |
| MINT-ALENDRONATE | 70.0MG | TABLET | Actual shortage | 2024-01-26 | 2024-01-26 | 217366 |
| MINT-ROSUVASTATIN | 5MG | TABLET | Actual shortage | 2019-08-22 | 2019-08-23 | 92272 |
| MINT-ROSUVASTATIN | 20MG | TABLET | Actual shortage | 2019-08-22 | 2019-08-23 | 92275 |
| MINT-LOSARTAN | 25.0MG | TABLET | Actual shortage | 2019-01-03 | 2020-01-27 | 71069 |
| MINT-LOSARTAN | 50.0MG | TABLET | Actual shortage | 2020-04-25 | 2020-04-25 | 113187 |
| MINT-LOSARTAN | 100.0MG | TABLET | Actual shortage | 2020-04-25 | 2020-04-25 | 113190 |
| MINT-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2018-03-09 | 2018-03-10 | 42370 |
| MINT-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2018-04-06 | 2018-04-07 | 45117 |
| MINT-ZOLMITRIPTAN | 2.5MG | TABLET | Actual shortage | 2020-04-25 | 2020-04-25 | 113199 |
| MINT-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-03-19 | 2024-03-19 | 222750 |
| MINT-GLICLAZIDE MR | 60MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2020-03-09 | 2020-03-10 | 108289 |
| MINT-CITALOPRAM | 20MG | TABLET | Actual shortage | 2020-07-28 | 2023-01-03 | 121276 |
| MINT-CITALOPRAM | 40MG | TABLET | Actual shortage | 2020-07-28 | 2023-01-03 | 121279 |
| MINT-LEVOCARB | 10MG 100MG | TABLET | Actual shortage | 2017-12-08 | 2017-12-09 | 32263 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MINT-FENOFIBRATE E | 145MG | TABLET | Discontinued | 2020-04-25 | 2020-04-25 | 113175 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
| MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
| MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
| MINT-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170853 |
| MINT-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170856 |
| MINT-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2022-10-02 | 2022-10-03 | 170859 |
| MINT-CITALOPRAM | 20MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191439 |
| MINT-CITALOPRAM | 40MG | TABLET | Discontinued | 2023-05-02 | 2023-05-03 | 191442 |